NASDAQ:GMDA
Delisted

Gamida Cell Stock Signals

etoro logo Buy GMDA
*Your capital is at risk
$0.0327
+0 (+0%)
At Close: Aug 27, 2024

Latest Data & Signals Issued

Below are some of the latest signals issued for Gamida Cell Ltd.

General

Signal Type Signal Value Data
Score 0.000 98 days ( 0 %
Last Price $0.0327 0 %
Performance History
7 Days
$0.0327 $0.0327
0%
30 Days
$0.0327 $0.0327
0%
12 Mos
$1.24 $0.0327
-97.36%

4/18

Active Buy Signals

Specific Signals

Short Term
Net score: 25
Signal Type Signal Value Importance Data
High / Low N/A Very Low $0.0327 - $0.0327
Trend - 3 mos 0 % High Width: 0.00000000000017 %
Pred. range - 3 mos $0.0327 - $0.0327 Low 0 % - 0 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Aug 26, 2024 - 2 days
RSI Short Pivot Signal Sell Very Low Nov 30, -0001 - N/A days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days
Short/Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 16.93
Signal Type Signal Value Importance Data
Trend - 12 mos -84.43 % Very High Width: 134.64 %
Pred. range - 12 mos N/A - $0.0309 High -100.00 % - -5.48 %
Short MA 12 mos Sell Very High Mar 22, 2024 - 109 days
Long MA 12 mos Sell Very High Mar 22, 2024 - 109 days
Short/Long MA 12 mos Sell Very High Nov 30, -0001 - N/A days
Pivot Long Buy Low Apr 05, 2024 - 100 days
RSI Long Pivot Signal Buy Low Apr 30, 2024 - 83 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT GAMIDA CELL LTD.
Gamida Cell
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials in patients with severe aplastic anemia. It is also developing GDA-201, a natural killer cell-based can...
GOLDEN STAR
Ticker Change Signal Date

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE